December 26, 2024
Focus On the Main Business, Continuous Innovation, Resilient Growth
In H1 2024, the company advanced innovation, expanded international markets, and drove product upgrades. Key highlights include the industrialization of stevioside RM, NHDC national standard approval, and rapid growth of "Sweet Compound Taste" and "Flying to the Moon" brands.
Read More